Combination, pharmaceutical composition, kit, cancer treatment method, method for reducing a level of cells, method for reducing the level of cells, method for increasing activity, method for increasing cytotoxicity
ALAIN ROLLAND,MIREILLE GILLINGS,REID P. BISSONNETTE
申请号：
BR112018073328
公开号：
BR112018073328A2
申请日:
2017.05.11
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
These are combinations that include a HDACi inhibitor and a PD -l1 inhibitor that are useful for cancer treatment, including cancer resistant to PD -1 inhibitors.trata-se de combinações que incluem um inibidor de hdaci e um inibidor de pd-l1 que são úteis para o tratamento de câncer, incluindo câncer resistente aos inibidores de pd-1.
